Navigation Links
Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Date:8/30/2007

SHENZHEN, China, Aug. 30 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Xu Hang, Chairman and Co-Chief Executive Officer, Ms. Joyce Hsu, Chief Financial Officer and Mr. Ting Yang, Vice President of European Markets will attend the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference. The conference will be held from September 18 to 20, 2007 at the Renaissance Chancery Court Hotel in London, England. Mr. Xu will present at 2:20 p.m. GMT on Wednesday, September 19, 2007.

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Boston, Istanbul, London, Mumbai, Seattle and Vancouver. For more information, please visit http://www.mindray.com .

For more information, please contact:

In China:

Investor Relations

Mindray Medical International Limited

Tel: +86-755-2658-2518

Email: IR@Mindray.com

Justin Knapp

Ogilvy Public Relations Worldwide, Beijing

Tel: +86-10-8520-6556

Email: Justin
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , SEATTLE, Nov. 24 Blue Mar...and the Odessa Public Development Authority (OPDA)...ate,s Community Economic Revitalization Board (CER...e state,s first specialty biochemical biorefinery ...ll significantly speed the development of our bior...
(Date:11/24/2009)... , , Primary efficacy endpoint has been ...ent endometrial cancer, , QUEBEC CITY, Nov. 2...NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a globa...herapy and oncology, today announced positive effi...ytotoxic peptide conjugate, AEZS-108 (formerly AN-...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-Firs...he global specialty biopharmaceutical company, tod...ropean Medicines Agency for,velaglucerase alfa, th...ent,for the treatment of Type 1 Gaucher disease. T...cerase alfa that has been submitted, with previous...
(Date:11/24/2009)... , REDWOOD CITY, Calif., Nov. 24 /PRNewswi...DX ) today announced that Randy Scott, Genomic Hea... Annual Piper Jaffray Health Care Conference in Ne...a.m. ET. ,, To access the live and subsequentl...Investor Relations section of Genomic Health,s web...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...n induce stress,but caring for children with diabe... of pressure. Parents and caregivers can visit, ht... live Web chats with,diabetes specialists for expe... during the holidays, find social support and rece...klet for tips on healthy eating. The Web site and...
...inhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Produ...nnounced that revenues for the first nine months o...30,442 in the first nine months of 2006. Revenues...increase of,226% compared to $906,068 in the third...due to the growth of Kiwa,s new bio-enhanced feed ...
...Nasdaq: MEDX ) today announced that Marc Rubin, M...ectors to serve as a director on Medarex,s Board,e... and CEO of Titan Pharmaceutical, Inc., a,biopharm...Stock Exchange.,Prior to joining Titan in October ...nt for Bayer Schering Pharma and a member of the E...
Other Biology Technology:New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 3Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 4Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 5Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 6Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 7Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 8Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 9Medarex Announces Election of Marc Rubin as New Board Member 2
(Date:11/23/2009)... November 23, 2009 Applied mathematicians dissect...cifolia ), a characteristic long leaf with a saddl...long the edges. The simple cause of the lily,s fan...ng during differential growthwas revealed by using...ons. , Haiyi Liang, a postdoctoral student at Ha...
(Date:11/23/2009)...e than 160 participants gathered this week for the...ITIATIVE conference. This year,s topic, "Synthetic... and medical researchers to explore the engineerin...merging field of synthetic biology. , Bonnie L. ...on University and this year,s conference chair, ch...
(Date:11/23/2009)...ly swine vaccine available for the H1N1 virus has ...the virus. The vaccination marks the first time va... the pandemic flu., Iowa State University,s Hank...e vaccine this summer and has been shipping preven...Illinois for several weeks., The latest vaccines...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 1Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 2Is your environment damaging your health 3F New center aims to find out 47466 1Is your environment damaging your health 3F New center aims to find out 47466 2Is your environment damaging your health 3F New center aims to find out 47466 3Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities 12389 1Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities 12389 2Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities 12389 3
...ost of us are familiar with the winding staircase ...s genetic information. But few of us realize just...tretched to its full length, a single molecule of ...wound up inside the nucleus of a cell, that same m...ross. Biologists have long believed that as a mole...
...cosystems behave in unpredictable ways and, becaus...with unforeseen challenges. Researchers, in a rec...e that restoration methods of the past may not alw...gest potential challenge ahead is restoring enviro... the earth,s history. This global climate change ...
...cientific travelers of the 18th and 19th centuries...etting oceans of discoveries about its geography, ...han simply courageous collectors of artifacts and ...eafaring naturalists were the producers and mediat...ge," argues historian Harry Liebersohn, the author...
Other Biology News:Surprise finding for stretched DNA 2Surprise finding for stretched DNA 3Polynesia explorers created worldwide web of scientific knowledge 2Polynesia explorers created worldwide web of scientific knowledge 3Polynesia explorers created worldwide web of scientific knowledge 4
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Essential Data: Gel Electrophoresis from Promega
Human MMP-7 (Total) ELISpot Kit from R&D Systems
...Kit, 1. Select from homogeneous and gradient polya...enaturing, native, and isoelectric focusing gels.S...gels, buffer strips, and staining kits.Achieve det...opes with ready-to-use silver staining kits. Categ...
Biology Products: